Erratum to Effect of Ginkgo Biloba on Visual Field and Contrast Sensitivity in Chinese Patients With Normal Tension Glaucoma: A Randomized, Crossover Clinical Trial(Invest Ophthalmol Vis Sci., (2014), 55, (110-116) 10.1167/iovs.13-13168);Effect of ginkgo biloba on visual field and contrast sensitivity in Chinese patients with normal tension glaucoma: A randomized, crossover clinical trial

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 1, 2013, Pages 110-116

  Guo, Xinxing ^a   Kong, Xiangbin ^a   Huang, Rui ^a   Jin, Ling ^a   Ding, Xiaohu ^a   He, Mingguang ^a   Liu, Xing ^a   Congdon, Nathan G ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b ORBIS INTERNATIONAL   (United States)

Author keywords

Contrast sensitivity; Ginkgo biloba; Normal tension glaucoma; Visual field

Indexed keywords

GINATON; GINKGO BILOBA EXTRACT; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CENTRAL CORNEAL THICKNESS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTRAST SENSITIVITY; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG CAPSULE; FEMALE; FOLLOW UP; HUMAN; LOW TENSION GLAUCOMA; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; VISUAL ACUITY; VISUAL FIELD;

EID: 84891879587     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-13168a     Document Type: Erratum

References (38)

1. Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol. 2012;96:614-618.
2. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262-267.
3. Thulasiraj RD, Nirmalan PK, Ramakrishnan R, et al. Blindness and vision impairment in a rural south Indian population: the Aravind Comprehensive Eye Survey. Ophthalmology. 2003; 110:1491-1498.
4. Dandona LD, Dandona R, Srinivas M, et al. Blindness in the Indian state of Andhra Pradesh. Invest Ophthalmol Vis Sci. 2001;42:908-916.
5. Ramakrishnan R, Nirmalan PK, Krishnadas R, et al. Glaucoma in a rural population of southern India: the Aravind comprehensive eye survey. Ophthalmology. 2003;110:1484-1490.
6. Dandona LD, Dandona R, Srinivas M, et al. Open-angle glaucoma in an urban population in southern India: the Andhra Pradesh eye disease study. Ophthalmology. 2000;107: 1702-1709.
7. Birks J, Grimley Evans J. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev. 2007;2:CD003120.
8. Hilton MP, Zimmermann EF, Hunt WT. Ginkgo biloba for tinnitus. Cochrane Database Syst Rev. 2013;3:CD003852.
9. Evans JR. Ginkgo biloba extract for age-related macular degeneration. Cochrane Database Syst Rev. 2013;1: CD001775.
10. Nicolai SP, Kruidenier LM, Bendermacher BI, et al. Ginkgo biloba for intermittent claudication. Cochrane Database Syst Rev. 2013;6:CD006888.
11. Hirooka K, Tokuda M, Miyamoto O, Itano T, Baba T, Shiraga F. The Ginkgo biloba extract (EGb 761) provides a neuroprotective effect on retinal ganglion cells in a rat model of chronic glaucoma. Curr Eye Res. 2004;28:153-157.
12. Zeng X, Liu M, Yang Y, Li Y, Asplund K. Ginkgo biloba for acute ischaemic stroke. Cochrane Database Syst Rev. 2005;4: CD003691.
13. Janssen IM, Sturtz S, Skipka G, Zentner A, Velasco Garrido M, Busse R. Ginkgo biloba in Alzheimer's disease: a systematic review. Wien Med Wochenschr. 2010;160:539-546.
14. West AL, Oren GA, Moroi SE. Evidence for the use of nutritional supplements and herbal medicines in common eye diseases. Am J Ophthalmol. 2006;141:157-166.
15. Cybulska-Heinrich AK, Mozaffarieh M, Flammer J. Ginkgo biloba: an adjuvant therapy for progressive normal and high tension glaucoma. Mol Vis. 2012;18:390-402.
16. Chung HS, Harris A, Kristinsson JK, Ciulla TA, Kagemann C, Ritch R. Ginkgo biloba extract increases ocular blood flow velocity. J Ocul Pharmacol Ther. 1999;15:233-240.
17. Park JW, Kwon HJ, Chung WS, Kim CY, Seong GJ. Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma. Korean J Ophthalmol. 2011;25:323-328.
18. Quaranta L, Bettelli S, Uva MG, Semeraro F, Turano R, Gandolfo E. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma. Ophthalmology. 2003; 110:359-362.
19. Lee J, Sohn SW, Kee C. Effect of Ginkgo biloba extract on visual field progression in normal tension glaucoma. J Glaucoma. 2013;22:780-784.
20. Khoury R, Cross JM, Girkin CA, Owsley C, McGwin G Jr. The association between self-reported glaucoma and ginkgo biloba use. J Glaucoma. 2009;18:543-545.
21. Wan MJ, Daniel S, Kassam F, et al. Survey of complementary and alternative medicine use in glaucoma patients. J Glaucoma. 2012;21:79-82.
22. Wang D, Huang W, Li Y, et al. Intraocular pressure, central corneal thickness, and glaucoma in chinese adults: the liwan eye study. Am J Ophthalmol. 2011;152:454-462.
23. Wang NL, Friedman DS, Zhou Q, et al. A population-based assessment of 24-hour intraocular pressure among subjects with primary open-angle glaucoma: the handan eye study. Invest Ophthalmol Vis Sci. 2011;52:7817-7821.
24. Liang YB, Friedman DS, Zhou Q, et al. Prevalence of primary open angle glaucoma in a rural adult Chinese population: the Handan eye study. Invest Ophthalmol Vis Sci. 2011;52:8250-8257.
25. Krupin T, Liebmann JM, Greenfield DS, Ritch R, Gardiner S. A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study. Am J Ophthalmol. 2011;151:671-681.
26. Musch DC, Lichter PR, Guire KE, Standardi CL. The Collaborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled patients. Ophthalmology. 1999;106:653-662.
27. Keltner JL, Johnson CA, Cello KE, et al. Visual field quality control in the Ocular Hypertension Treatment Study (OHTS). J Glaucoma. 2007;16:665-669.
28. Noordzij M, Tripepi G, Dekker FW, Zoccali C, Tanck MW, Jager KJ. Sample size calculations: basic principles and common pitfalls. Nephrol Dial Transplant. 2010;25:1388-1393.
29. Hills M, Armitage P. The two-period cross-over clinical trial. Br J Clin Pharmacol. 1979;8:7-20.
30. Shim SH, Kim JM, Choi CY, Kim CY, Park KH. Ginkgo biloba extract and bilberry anthocyanins improve visual function in patients with normal tension glaucoma. J Med Food. 2012;15: 818-823.
31. Gillespie BW, Musch DC, Guire KE, et al. The collaborative initial glaucoma treatment study: baseline visual field and testretest variability. Invest Ophthalmol Vis Sci. 2003;44:2613-2620.
32. Fogagnolo P, McNaught A, Centofanti M, Rossetti L, Orzalesi N. The effects of intraocular pressure reduction on perimetric variability in glaucomatous eyes. Invest Ophthalmol Vis Sci. 2007;48:4557-4563.
33. Richman J, Lorenzana LL, Lankaranian D, et al. Importance of visual acuity and contrast sensitivity in patients with glaucoma. Arch Ophthalmol. 2010;128:1576-1582.
34. Lahav K, Levkovitch-Verbin H, Belkin M, Glovinsky Y, Polat U. Reduced mesopic and photopic foveal contrast sensitivity in glaucoma. Arch Ophthalmol. 2011;129:16-22.
35. Onal S, Yenice O, Cakir S, Temel A. FACT contrast sensitivity as a diagnostic tool in glaucoma: FACT contrast sensitivity in glaucoma. Int Ophthal. 2008;28:407-412.
36. Wimpissinger B, Berisha F, Garhoefer G, Polak K, Schmetterer L. Influence of Ginkgo biloba on ocular blood flow. Acta Ophthalmol. 2007;85:445-449.
37. Amieva H, Meillon C, Helmer C, Barberger-Gateau P, Dartigues JF. Ginkgo biloba extract and long-term cognitive decline: a 20-year follow-up population-based study. PLoS One. 2013;8: e52755.
38. Jones B, Lewis JA. The case for cross-over trials in phase III. Stat Med. 1995;14:1025-1038.